Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations

Despite the known contributions of genes, genetic-guided pharmacotherapy has not been routinely implemented for venous thromboembolism (VTE). To examine evidence on cost-effectiveness of genetic-guided pharmacotherapy for VTE, we searched six databases, websites of four HTA agencies and citations, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ka Keat, Koleva-Kolarova, Rositsa, Chowienczyk, Philip, Wolfe, Charles D. A., Fox-Rushby, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602036/
https://www.ncbi.nlm.nih.gov/pubmed/34131314
http://dx.doi.org/10.1038/s41397-021-00243-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602036/
https://www.ncbi.nlm.nih.gov/pubmed/34131314
http://dx.doi.org/10.1038/s41397-021-00243-7

Ejemplares similares